Skip to content

Utrecht Coronary Biobank (UCORBIO)

Utrecht Coronary Biobank (UCORBIO)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02304744
Acronym
UCORBIO
Enrollment
3000
Registered
2014-12-02
Start date
2011-10-31
Completion date
2019-12-31
Last updated
2015-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

UCORBIO enrolls patients who undergo coronary angiography (for any indication). The investigators draw blood at the moment of insertion of the procedural arterial catheter. At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed. Patients are then followed-up for the occurrence of major adverse cardiovascular events for 5 years. During the follow-up period patients receive a questionnaire every year to check for hospital admissions. The questionnaires at two and five years of follow-up are enriched with quality of life questionnaires (RAND-36 and EuroQoL).

Interventions

OTHERObservational study, no intervention.

Observational study, no intervention.

Sponsors

UMC Utrecht
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Coronary angiography

Exclusion criteria

* Age \< 18 years.

Design outcomes

Primary

MeasureTime frameDescription
major adverse cardiovascular events [MACE] (Stroke, myocardial infarction, coronary revascularization, death)5 yearsStroke, myocardial infarction, coronary revascularization, death.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026